PET/CT imaging of chemokine receptors in inflammatory atherosclerosis using targeted nanoparticles

Journal of Nuclear Medicine

Volumn 57, Issue 7, 2016, Pages 1124-1129

  Luehmann, Hannah P ^a   Detering, Lisa ^a   Fors, Brett P ^b   Pressly, Eric D ^b   Woodard, Pamela K ^a   Randolph, Gwendalyn J ^c   Gropler, Robert J ^a   Hawker, Craig J ^b   Liu, Yongjian ^a  

^a WASHINGTON UNIVERSITY   (United States)

^b University of California   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Atherosclerosis; Chemokine receptor; Nanoparticle; PET CT; Viral macrophage inflammatory protein II

Indexed keywords

APOLIPOPROTEIN E; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR3; CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CCR8; CHEMOKINE RECEPTOR CX3CR1; CHEMOKINE RECEPTOR CXCR4; MACROGOL; NANOPARTICLE; POLY(METHYL METHACRYLATE); RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; VIRAL MACROPHAGE INFLAMMATORY PROTEIN II CU 64; CHEMOKINE; COPPER; VMIP-II;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; BIOACCUMULATION; CHEMICAL REACTION; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; DISEASE COURSE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; ISOTOPE LABELING; MALE; MOUSE; NONHUMAN; PET-CT SCANNER; PHYSICAL CHEMISTRY; PHYSICAL PARAMETERS; POLYMERIZATION; PRIORITY JOURNAL; PROTEIN ASSEMBLY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYNTHESIS; UPREGULATION; ANIMAL; ANTAGONISTS AND INHIBITORS; ATHEROSCLEROTIC PLAQUE; C57BL MOUSE; CHEMISTRY; DIAGNOSTIC IMAGING; GENETICS; INFLAMMATION; KNOCKOUT MOUSE; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY-COMPUTED TOMOGRAPHY; PROCEDURES; TISSUE DISTRIBUTION;

ANIMALS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; CHEMOKINES; COPPER RADIOISOTOPES; INFLAMMATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NANOPARTICLES; PLAQUE, ATHEROSCLEROTIC; POSITRON EMISSION TOMOGRAPHY COMPUTED TOMOGRAPHY; RADIOPHARMACEUTICALS; RECEPTORS, CHEMOKINE; TISSUE DISTRIBUTION;

EID: 84978388880     PISSN: 01615505     EISSN: 2159662X     Source Type: Journal    
DOI: 10.2967/jnumed.115.166751     Document Type: Article

References (38)

1. Dong ZM, Brown AA, Wagner DD. Prominent role of P-selectin in the development of advanced atherosclerosis in ApoE-deficient mice. Circulation. 2000; 101:2290-2295.
2. Nakashima Y, Raines EW, Plump AS, Breslow JL, Ross R. Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse. Arterioscler Thromb Vasc Biol. 1998; 18:842-851.
3. Wildgruber M, Swirski FK, Zernecke A. Molecular imaging of inflammation in atherosclerosis. Theranostics. 2013; 3:865-884.
4. Kraaijeveld AO, de Jager SC, van Berkel TJ, Biessen EA, Jukema JW. Chemo-kines and atherosclerotic plaque progression: towards therapeutic targeting? Curr Pharm Des. 2007; 13:1039-1052.
5. Charo IF, Ransohoff RM. The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med. 2006; 354:610-621.
6. Libby P. Inflammation in atherosclerosis. Arterioscler Thromb Vasc Biol. 2012; 32: 2045-2051.
7. Braunersreuther V, Mach F, Steffens S. The specific role of chemokines in atherosclerosis. Thromb Haemost. 2007; 97:714-721.
8. John AE, Channon KM, Greaves DR. Chemokines, chemokine receptors and atherosclerosis. In: Schwiebert LM, ed. Chemokines, Chemokine Receptors, and Disease. Amsterdam, The Netherlands: Elsevier 2005:223-253.
9. Veillard NR, Steffens S, Burger F, Pelli G, Mach F. Differential expression patterns of proinflammatory and antiinflammatory mediators during atherogen-esis in mice. Arterioscler Thromb Vasc Biol. 2004; 24:2339-2344.
10. Veillard NR, Braunersreuther V, Arnaud C, et al. Simvastatin modulates chemo-kine and chemokine receptor expression by geranylgeranyl isoprenoid pathway in human endothelial cells and macrophages. Atherosclerosis. 2006; 188:51-58.
11. Gautier EL, Ivanov S, Lesnik P, Randolph GJ. Local apoptosis mediates clearance of macrophages from resolving inflammation in mice. Blood. 2013; 122:2714-2722.
12. Potteaux S, Gautier EL, Hutchison SB, et al. Suppressed monocyte recruitment drives macrophage removal from atherosclerotic plaques of Apoe2/2 mice during disease regression. J Clin Invest. 2011; 121:2025-2036.
13. Tacke F, Alvarez D, Kaplan TJ, et al. Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques. J Clin Invest. 2007; 117:185-194.
14. Quinones MP, Martinez HG, Jimenez F, et al. CC chemokine receptor 5 influences late-stage atherosclerosis. Atherosclerosis. 2007; 195:e92-e103.
15. Bursill CA, Channon KM, Greaves DR. The role of chemokines in atherosclerosis: recent evidence from experimental models and population genetics. Curr Opin Lipidol. 2004; 15:145-149.
16. White GE, Iqbal AJ, Greaves DR. CC chemokine receptors and chronic inflammation-therapeutic opportunities and pharmacological challenges. Pharmacol Rev. 2013; 65:47-89.
17. Zernecke A, Shagdarsuren E, Weber C. Chemokines in atherosclerosis: an update. Arterioscler Thromb Vasc Biol. 2008; 28:1897-1908.
18. Zernecke A, Weber C. Chemokines in the vascular inflammatory response of atherosclerosis. Cardiovasc Res. 2010; 86:192-201.
19. Jerath MR, Kwan M, Liu P, Patel DD. Chemokine receptors in atherosclerosis. In: Harrison JK, Lukacs NW, eds. The Chemokine Receptors. Totowa, New Jersey: Humana Press; 2007:199-233.
20. Bahal R, McNeer NA, Ly DH, Saltzman WM, Glazer PM. Nanoparticle for delivery of antisense gammaPNA oligomers targeting CCR5. Artif DNA PNA XNA. 2013; 4:49-57.
21. Leuschner F, Dutta P, Gorbatov R, et al. Therapeutic siRNA silencing in inflammatory monocytes in mice. Nat Biotechnol. 2011; 29:1005-1010.
22. Liu Y, Pierce R, Luehmann HP, Sharp TL, Welch MJ. PET imaging of chemokine receptors in vascular injury-accelerated atherosclerosis. J Nucl Med. 2013; 54:1135-1141.
23. Luehmann HP, Pressly ED, Detering L, et al. PET/CT imaging of chemokine receptor CCR5 in vascular injury model using targeted nanoparticle. J Nucl Med. 2014; 55:629-634.
24. Liu Y, Welch MJ. Nanoparticles labeled with positron emitting nuclides: advantages, methods, and applications. Bioconjug Chem. 2012; 23:671-682.
25. Liu Y, Pressly ED, Abendschein DR, et al. Targeting angiogenesis using a C-type atrial natriuretic factor-conjugated nanoprobe and PET. J Nucl Med. 2011; 52:1956-1963.
26. Pressly ED, Pierce RA, Connal LA, Hawker CJ, Liu Y. Nanoparticle PET/CT imaging of natriuretic peptide clearance receptor in prostate cancer. Bioconjug Chem. 2013; 24:196-204.
27. Perrier S, Takolpuckdee P. Macromolecular design via reversible addition-fragmentation chain transfer (RAFT)/xanthates (MADIX) polymerization. J Polym Sci A Polym Chem. 2005; 43:5347-5393.
28. Humenik M, Huang Y, Wang Y, Sprinzl M. C-terminal incorporation of bio-orthogonal azide groups into a protein and preparation of protein-oligodeoxynucleotide conjugates by Cu'-catalyzed cycloaddition. ChemBioChem. 2007; 8:1103-1106.
29. Zernecke A, Liehn EA, Gao JL, Kuziel WA, Murphy PM, Weber C. Deficiency in CCR5 but not CCR1 protects against neointima formation in atherosclerosis-prone mice: involvement of IL-10. Blood. 2006; 107:4240-4243.
30. Westrick RJ, Winn ME, Eitzman DT. Murine models of vascular thrombosis (Eitzman series). Arterioscler Thromb Vasc Biol. 2007; 27:2079-2093.
31. Liu Y, Ibricevic A, Cohen JA, et al. Impact of hydrogel nanoparticle size and functionalization on in vivo behavior for lung imaging and therapeutics. Mol Pharm. 2009; 6:1891-1902.
32. Drechsler M, Duchene J, Soehnlein O. Chemokines control mobilization, recruitment, and fate of monocytes in atherosclerosis. Arterioscler Thromb Vasc Biol. 2015; 35:1050-1055.
33. Horuk R. Promiscuous drugs as therapeutics for chemokine receptors. Expert Rev Mol Med. 2009; 11:e1.
34. Horuk R. Chemokine receptor antagonists: overcoming developmental hurdles. Nat Rev Drug Discov. 2009; 8:23-33.
35. Nahrendorf M, Zhang H, Hembrador S, et al. Nanoparticle PET-CT imaging of macrophages in inflammatory atherosclerosis. Circulation. 2008; 117:379-387.
36. Moore KJ, Sheedy FJ, Fisher EA. Macrophages in atherosclerosis: a dynamic balance. Nat Rev Immunol. 2013; 13:709-721.
37. Tarkin JM, Joshi FR, Rudd JH. PET imaging of inflammation in atherosclerosis. Nat Rev Cardiol. 2014; 11:443-457.
38. PET imaging of natriuretic peptide receptor C (NPR-C) in carotid atherosclerosis. ClinicalTrials.gov website. https://www.clinicaltrial.gov/ct2/show/NCT02417688?term5woodard&rank513. Updated December 14, 2015. Accessed February 26, 2016.